Related Experiment Videos

Antibiotic resistance of clinical isolates of Streptococcus pneumoniae in Greece

S Kanavaki1, S Karabela, E Marinis

  • 1Laboratory of Clinical Microbiology, Chest Hospital, Athens, Greece.

Insights

Antibiotic resistance in Streptococcus pneumoniae is a growing concern for community-acquired pneumonia. This study found significant resistance rates to common antibiotics like penicillin and erythromycin.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Community-acquired pneumonia (CAP) poses a significant public health challenge.
  • Streptococcus pneumoniae is a primary causative agent of CAP.
  • Antibiotic resistance in S. pneumoniae complicates treatment and impacts patient outcomes.

Purpose of the Study:

  • To determine the antibiotic susceptibility patterns of clinical isolates of Streptococcus pneumoniae.
  • To assess the prevalence of resistance to key antibiotics used in treating CAP.

Main Methods:

  • Analysis of 1,002 clinical isolates of Streptococcus pneumoniae.
  • Determination of antibiotic susceptibility testing over an 18-month period.
  • Statistical analysis to identify associations between resistance patterns.

Main Results:

  • Penicillin resistance was observed in 14% of isolates.
  • Erythromycin resistance was 20%, and tetracycline resistance was 26%.
  • Chloramphenicol resistance was low at 1%; resistance to non-beta-lactam antibiotics correlated with penicillin resistance.

Conclusions:

  • Significant levels of antibiotic resistance exist in Streptococcus pneumoniae causing CAP.
  • Penicillin and erythromycin resistance are notable concerns.
  • Monitoring antibiotic susceptibility is crucial for effective CAP management.

Related Concept Videos